PMID: 11337819May 8, 2001Paper

Docosahexaenoic acid--induced vasorelaxation in hypertensive rats: mechanisms of action

Biological Research for Nursing
M B Engler, M B Engler

Abstract

The authors investigated the vasorelaxant properties of the omega-3 fatty acid, docosahexaenoic (DHA, 22:6n-3), and the possible involvement of endothelium-derived nitric oxide, prostanoids, opening of K+ channels, and/or modulation of calcium-mediated events. Isolated aorta from male spontaneously hypertensive rats (SHR) (age 16-17 weeks) were used to measure isometric tension. DHA-induced (1-100 mumol/l) relaxation was examined following contraction to norepinephrine (NE) (10(-6) mol/l) or high-K+ (80 mmol/l) solution in the presence and absence of various inhibitors and calcium-containing solution. DHA acid induced a significant vasorelaxant effect in both NE and high-K(+)-induced contracted SHR aortic rings, although DHA relaxations were greater in high-K(+)-induced contracted rings. In the absence of extracellular calcium, DHA (5-30 mumol/l) inhibited the initial phasic and sustained components of NE-induced contraction under different conditions. Inhibition of nitric oxide synthesis by N omega-nitro-L-arginine methyl ester hydrochloride (100 mumol/l) had no effect on DHA relaxations; however, indomethacin or nifedipine caused significant inhibition at > or = 30 mumol/l DHA. The K+ channel blocker, glibenclamide, but not t...Continue Reading

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H HallaqA Leaf
May 1, 1992·Canadian Journal of Physiology and Pharmacology·M B Engler
Feb 1, 1992·Hypertension·T F LüscherZ H Yang
Oct 1, 1991·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P R HoweY Lungershausen
Jul 1, 1990·The American Journal of Clinical Nutrition·J E KinsellaR A Stone
Oct 1, 1990·American Journal of Hypertension·P D LevinsonM Steiner
Aug 1, 1989·Trends in Pharmacological Sciences·H Karaki
Dec 15, 1988·Biochemical and Biophysical Research Communications·J NishimuraC van Breemen
Jan 1, 1981·Progress in Lipid Research·N W Schoene, D Fiore
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·S PepeE Lakatta
Mar 1, 1995·Clinical and Experimental Pharmacology & Physiology·P R Howe
Jun 1, 1994·Journal of Pharmacological and Toxicological Methods·G R MonteithB D Roufogalis
Sep 1, 1993·Trends in Pharmacological Sciences·U Quast
Feb 9, 1993·European Journal of Pharmacology·M D IvorraM P D'Ocon
Aug 1, 1995·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·E Nava, T F Lüscher
Apr 16, 1996·Biochemical and Biophysical Research Communications·J V MombouliP M Vanhoutte
Feb 1, 1996·Prostaglandins, Leukotrienes, and Essential Fatty Acids·H W ChenC C Ou
Jan 1, 1997·Progress in Cardiovascular Diseases·G R De Meyer, A G Herman
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y F XiaoA Leaf
May 26, 1998·The Journal of Pharmacy and Pharmacology·M CatretE Anselmi
Jan 5, 2000·American Journal of Hypertension·M B EnglerM M Engler
Jan 5, 2001·British Journal of Pharmacology·M B EnglerR Sievers

❮ Previous
Next ❯

Citations

Oct 14, 2008·Genes & Nutrition·Marilena Minieri, Paolo Di Nardo
Apr 20, 2005·International Journal of Cardiology·Marcia B AguilaCarlos A Mandarim-de-Lacerda
Jun 6, 2003·The Journal of Surgical Research·Isabel Calvo Del CastilloJeffrey B Matthews
Feb 26, 2011·The Proceedings of the Nutrition Society·S C CottinW L Hall
Dec 16, 2010·The Journal of Pharmacology and Experimental Therapeutics·Xiang LiYang Zhang
Apr 26, 2003·The British Journal of Ophthalmology·A HommerUNKNOWN Unoprostone Adjunctive Therapy Study Group
Apr 4, 2008·American Journal of Physiology. Renal Physiology·Montserrat M Diaz EncarnacionJoseph P Grande
Sep 10, 2013·International Journal of Cardiology·Roberto Marchioli, Giacomo Levantesi
Dec 7, 2013·Journal of Smooth Muscle Research = Nihon Heikatsukin Gakkai Kikanshi·Kyosuke SatoYoshio Tanaka
Jan 27, 2016·The Journal of Nutrition, Health & Aging·X ChenJ Shi
May 25, 2004·Seminars in Nephrology·James V Donadio, Joseph P Grande
Jul 28, 2016·International Journal of Food Sciences and Nutrition·Kolbrun SveinsdottirAlfons Ramel
Nov 9, 2016·European Journal of Pharmacology·Arizai Yolia Landa-JuárezAracely Evangelina Chávez-Piña
Apr 3, 2014·Journal of Cardiovascular Pharmacology·Arzu UluBruce D Hammock
Aug 13, 2002·Journal of Hypertension·Johanna M GeleijnseFrans J Kok
May 1, 2020·Antioxidants & Redox Signaling·Hui WangXu Zhang
Aug 27, 2003·Journal of Pharmacological Sciences·Masahiko HirafujiMasaru Minami
Jan 13, 2006·The Journal of Cardiovascular Nursing·Marguerite M Engler, Mary B Engler
Aug 5, 2004·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Klaus K A Witte, Andrew L Clark
Mar 11, 2003·Experimental Biology and Medicine·Marguerite M EnglerAgostino Molteni
Jan 19, 2021·International Journal of Vascular Medicine·Diva M VillalpandoMercedes Ferrer
Feb 5, 2021·Journal of the American College of Cardiology·Richard L WeinbergKim A Eagle
Jun 11, 2008·The American Journal of Clinical Nutrition·Un Ju JungRichard J Deckelbaum
Aug 1, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Armond DaciGokce Topal
Jun 16, 2021·Critical Reviews in Food Science and Nutrition·Jaime López-SeoaneHelios Pareja-Galeano
Aug 26, 2017·Prostaglandins & Other Lipid Mediators·Armond DaciGökce Topal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.